Skip to Content Skip to Main Navigation Skip to Local Navigation Skip to Search

Decrease the text size Increase the text size Print this page

AusPAR: Ceftolozane (as sulfate) / Tazobactam (as sodium salt)

Related information

How to access a pdf or Word document

15 February 2016

AusPAR Details
AusPAR	AusPAR: Ceftolozane (as sulfate) / Tazobactam (as sodium salt) (pdf, 1 MB) AusPAR: Ceftolozane (as sulfate) / Tazobactam (as sodium salt) (docx, 2 MB) Attachment: Product Information: Ceftolozane (as sulfate) / Tazobactam (as sodium salt) (pdf, 329 KB) Attachment: Product Information: Ceftolozane (as sulfate) / Tazobactam (as sodium salt) (doc, 255 KB) Attachment: Extract from Clinical Evaluation Report: Ceftolozane (as sulfate) / Tazobactam (as sodium salt) (pdf, 1 MB) Attachment: Extract from Clinical Evaluation Report: Ceftolozane (as sulfate) / Tazobactam (as sodium salt) (docx, 935 KB)
Active Ingredient	Ceftolozane (as sulfate) / Tazobactam (as sodium salt)
Product Name	Zerbaxa
Sponsor	Merck Sharp & Dohme Australia Pty Ltd
Submission Number	PM-2014-03153-1-2
Submission Type	New chemical entity
Decision	Approved
AusPAR Date	27 January 2016
Publication Date	15 February 2016

Category:

Prescription medicines

Tags:

AusPARs

URL:

https://www.tga.gov.au/node/713841